Globalmente, os carcinomas uroteliais representam o quarto tipo de neoplasia mais comum, após os tumores da próstata (ou mama), pulmão e colorectais, com cerca de 260 mil novos casos diagnosticados anualmente a nível mundial. Destes, os Carcinomas Uroteliais do Trato Urinário Superior (UTUC, i.e., com origem no bacinete e ureteres), devido à sua origem e localização, são particularmente susceptíveis de invadir as estruturas adjacentes, tendo assim um maior potencial de agressividade.
The Bluepharma | University of Coimbra Innovation Award is attributed every 2 years to an innovative research project in the health area. All research labs, institutes and organizations that host innovative research projects involving Portuguese researchers may apply.
These projects may be carried out by groups of more than one institution, but the research work must have been partially or totally conducted in Portuguese institutions, by Portuguese and/or foreign researchers.
The Bluepharma | University of Coimbra Innovation Award is attributed every 2 years to an innovative research project in the health area. All research labs, institutes and organizations that host innovative research projects involving Portuguese researchers may apply.
These projects may be carried out by groups of more than one institution, but the research work must have been partially or totally conducted in Portuguese institutions, by Portuguese and/or foreign researchers.
